Crescent Capital BDC, Inc. (CCAP) Fair Value 2026

CCAP · Asset Management ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.6 /10

32 fundamental signals · 6 models active

Value Trap Risk

WARN (49/100)

Quick Summary — As of 2026-08-28, Crescent Capital BDC, Inc. (CCAP) trades at $10.54, versus a $14.81 median fair value across its 6 active models — 40.5% above the current price. QOC: 5.6/10. Value Trap Risk: 49/100 (WARN). 6/13 models active. Within that set, the Bayesian DCF component alone returns $63.23.

Key Facts

Ticker
CCAP
Price
$10.54
Quality Score
5.6/10
Value Trap Risk
49/100
Models Active
6/13
Last Updated
Strength: Bayesian DCF suggests +499.9% upside with 32% confidence
Risk: Value Trap score of 49 suggests caution despite apparent undervaluation

Is Crescent Capital BDC, Inc. (CCAP) Undervalued or Overvalued in 2026?

According to CirclFi’s 6-model valuation engine, Crescent Capital BDC, Inc. (CCAP) appears undervalued as of : the median of 6 independent fair value estimates is $14.81, 40.5% above the current price of $10.54. Estimates range from $9.13 to $63.23. CCAP scores 5.6/10 on fundamental quality and 49/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. CCAP’s +40.5% gap is wider than that market norm, and the Asset Management sector median is -4.4%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Crescent Capital BDC, Inc. Stock in 2026? →

What Fair Value Does Each Model Give CCAP?

6 Intrinsic Value Models vs. Current Price ($10.54)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · Medium Conviction
 $63.23 +499.9%
Ensemble · Low Conviction
 $16.47 +56.3%
Intrinsic · Medium Conviction
 $13.14 +24.7%
Unlock the Full Matrix

Access 3 additional models including PWERM, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 6 Models →

Cancel anytime · No contracts · Instant access

What Is CCAP's Fair Value Range?

Spread across 6 independent models · $9.13 to $63.23

CirclFi's 6 active models place Crescent Capital BDC, Inc. (CCAP) between $9.13 and $63.23 per share, a spread of 365% of the median. The median of that range — $14.81 — is the fair value CirclFi publishes for CCAP, against a current price of $10.54.

Low · PWERMHigh · Bayesian DCF
$9.13median $14.81$63.23
Where the range comes from
Most bearish modelPWERM$9.13
Most bullish modelBayesian DCF$63.23
Model agreement5 bullish · 1 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for CCAP. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on CCAP, not a CirclFi price target. How each model works →

What Is Crescent Capital BDC, Inc. (CCAP) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for Crescent Capital BDC, Inc.. Trading at $10.54 against an estimated intrinsic value of $14.81, 5 of 6 active models flag meaningful upside of +40.5% at the median. The most optimistic model, Bayesian DCF, places fair value at $63.23 (+499.9%), while PWERM — the most conservative — estimates $9.13 (-13.4%). This +513.3% gap reflects genuine analytical uncertainty about Crescent Capital BDC, Inc.'s intrinsic worth.

What Do the Models Say About CCAP?

6 of 13 models are currently active for CCAP. Of these, 5 models suggest upside while 1 model suggests overvaluation. Taken together, their median fair value for CCAP is $14.81 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $63.23 on its own, implying +499.9% upside from the current price. See which stocks rank higher →

How Does CCAP Rank in Asset Management?

Among 187 Asset Management stocks, CCAP ranks #89 by Quality of Company score. CirclFi's QOC score of 5.6/10 evaluates 32 fundamental signals. A score of 5.6 reflects mixed fundamentals.

See all Most Undervalued Asset Management Stocks →

Crescent Capital BDC, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is CCAP a Value Trap?

CirclFi's Value Trap algorithm assigns CCAP a score of 49/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

6 of 13 models are active for Crescent Capital BDC, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Crescent Capital BDC, Inc.'s fundamental quality profile registers 5.6/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +513.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CCAP valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across CCAP's 6 active models, average confidence is 21%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Crescent Capital BDC, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Asset Management Stocks Should You Also Analyze?

11 related Asset Management stocks with 13-model coverage

CIONCION Investment CorporationQOC 5.6PIACPrinceton Capital CorporationQOC 5.5CGBDCarlyle Secured Lending, Inc.QOC 5.6SLRCSLR Investment Corp.QOC 5.5MFICMidCap Financial Investment CorporationQOC 5.7HSDTSolana CompanyQOC 5.5ZSTKZeroStack Corp.QOC 4.8DXYZDestiny Tech100 Inc.QOC 2.2KKRKKR & Co. Inc.QOC 7.1HLNEHamilton Lane IncorporatedQOC 9.3AMPAmeriprise Financial, Inc.QOC 9.3

Read investment analysis: CION · PIAC · CGBD · SLRC · MFIC · HSDT · ZSTK · DXYZ · KKR · HLNE · AMP

Which Other Stocks Have a Similar Quality Score to CCAP?

7 companies across all industries closest to CCAP’s Quality of Company score of 5.6/10.

PLUTPlutus Financial Group LimitedQOC 5.6ASURAsure Software, Inc.QOC 5.6CVATCavitation Technologies, Inc.QOC 5.6GRPNGroupon, Inc.QOC 5.6WTERThe Alkaline Water Company Inc.QOC 5.6BLSHBullishQOC 5.6NVDANVIDIA CorporationQOC 10.0

Read investment analysis: PLUT · ASUR · CVAT · GRPN · WTER · BLSH · NVDA

Where Does CCAP Sit in CirclFi's Asset Management Rankings?

CCAP is ranked against every other Asset Management stock CirclFi covers in each of these screens.

See all Asset Management stocks ranked →

What Else Do Investors Ask About Crescent Capital BDC, Inc.’s Valuation?

What is Crescent Capital BDC, Inc.'s intrinsic value in 2026?

CirclFi puts Crescent Capital BDC, Inc. (CCAP)'s intrinsic value at $14.81 — the median of 6 independent model estimates as of 2026-08-28, ranging from $9.13 to $63.23. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $63.23 on its own. The Quality of Company score is 5.6/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CCAP overvalued or undervalued right now?

At $10.54, 5 of 6 active models suggest CCAP may be undervalued, while 1 indicate potential overvaluation. The median of all 6 fair value estimates is $14.81, 40.5% above the current price of $10.54 — a consensus view that CCAP is undervalued. The assessment depends on which methodology best fits Crescent Capital BDC, Inc.'s business model in Asset Management.

What does a Quality of Company score of 5.6 mean for CCAP?

Crescent Capital BDC, Inc.'s QOC of 5.6/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on CCAP?

CirclFi analyzes CCAP with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 6 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on CCAP?

Of the 6 models currently active on CCAP, Bayesian DCF is the most bullish at $63.23 per share, and PWERM is the most bearish at $9.13. CirclFi's published fair value for CCAP is the median of that range, $14.81, not either extreme. The gap between the two ends equals 365% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is CCAP a value trap in 2026?

Crescent Capital BDC, Inc.'s Value Trap score is 49/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries.

Cite this analysis — “According to CirclFi’s 6-model valuation engine, Crescent Capital BDC, Inc. (CCAP) has a median fair value of $14.81 — 40.5% above the current price of $10.54 — as of 2026-08-28.” Source: circlfi.com/stock/CCAP/ · Methodology
Primary sources for this CCAP valuation
  • Financial statements: Crescent Capital BDC, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001633336) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for CCAP as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 6 mathematical frameworks give you clarity on CCAP.

Unlock All 6 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

3 models hidden for CCAP Unlock All 6 — $39/mo